Stocks
GlaxoSmithKline (GSK) EV US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV, £ | ? | 161 063 840 000 | 83 846 820 000 | 154 583 640 000 | 165 189 660 000 | 163 003 120 000 | 153 040 250 000 | ||
| Changes by years, y/y, % | +49% | -48% | +84% | +7% | -1% | +10.9% | |||
GlaxoSmithKline. EV, £
GlaxoSmithKline. EV, changes, %
GlaxoSmithKline (GSK) EV US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV, £ | ? | 159 418 920 000 | 161 146 750 000 | 165 374 960 000 | 163 161 018 466 | 188 115 030 000 | 153 040 250 000 | |
| Changes by years, y/y, % | +55% | +117% | +7% | +5% | +19% | |||
| Changes by quarters, q/q, % | +51% | +1% | +3% | -1% | +15% | |||
